OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Release Date
2020
(2)
2010
(2)
2025
(1)
2024
(1)
2021
(1)
2019
(1)
2018
(1)
2016
(1)
2011
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Genomic features of rapid versus late relapse in triple negative breast cancer.
Not available
S-EPMC8130400
|
biostudies-literature
Cite
Stromal PTEN determines mammary epithelial response to radiotherapy.
Not available
S-EPMC6050339
|
biostudies-literature
Cite
INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell model.
Not available
S-EPMC12764576
|
biostudies-literature
Cite
A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors.
Not available
S-EPMC7518641
|
biostudies-literature
Cite
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.
Not available
S-EPMC6467310
|
biostudies-literature
Cite
Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.
Not available
S-EPMC2801744
|
biostudies-literature
Cite
Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.
Not available
S-EPMC3779435
|
biostudies-literature
Cite
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Not available
S-EPMC3235490
|
biostudies-literature
Cite
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Not available
S-EPMC11526018
|
biostudies-literature
Cite
Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study.
Not available
S-EPMC5050130
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets